Supreme Court Denies Lilly Certiorari Bid In Cialis Patent Row
WASHINGTON, D.C. — In its Oct. 21 orders list, the U.S. Supreme Court announced that it will not review an October 2018 summary affirmance by the Federal Circuit U.S. Court of...To view the full article, register now.
Already a subscriber? Click here to view full article